{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:20:43Z","timestamp":1790076043481,"version":"4.0.1"},"reference-count":69,"publisher":"European Respiratory Society (ERS)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2001,10,27]]},"published-print":{"date-parts":[[2002,4]]},"abstract":"<jats:p>As countries approach the elimination phase of tuberculosis, specific problems and challenges emerge, due to the steadily declining incidence in the native population, the gradually increasing importance of the importation of latent tuberculosis infection and tuberculosis from other countries and the emergence of groups at particularly high risk of tuberculosis.<\/jats:p><jats:p>Therefore, a Working Group of the World Health Organization (WHO), the International Union Against Tuberculosis and Lung Disease (IUATLD) and the Royal Netherlands Tuberculosis Association (KNCV) have developed a new framework for low incidence countries based on concepts and definitions consistent with those of previous recommendations from WHO\/IUATLD Working Groups.<\/jats:p><jats:p>In low-incidence countries, a broader spectrum of interventions is available and feasible, including: 1) a general approach to tuberculosis which ensures rapid detection and treatment of all the cases and prevention of unnecessary deaths; 2) an overall control strategy aimed at reducing the incidence of tuberculosis infection (risk-group management and prevention of transmission of infection in institutional settings) and 3) a tuberculosis elimination strategy aimed at reducing the prevalence of tuberculosis infection (outbreak management and provision of preventive therapy for specified groups and individuals).<\/jats:p><jats:p>Government and private sector commitment towards elimination, effective case detection among symptomatic individuals together with active case finding in special groups, standard treatment of disease and infection, access to tuberculosis diagnostic and treatment services, prevention (<jats:italic>e.g.<\/jats:italic>through screening and bacille Calmette-Gu\u00e9ria immunization in specified groups), surveillance and treatment outcome monitoring are prerequisites to implementing the policy package recommended in this new framework document.<\/jats:p>","DOI":"10.1183\/09031936.02.00261402","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T12:37:15Z","timestamp":1027773435000},"page":"765-775","source":"Crossref","is-referenced-by-count":208,"title":["European framework for tuberculosis control and elimination in countries with a low incidence"],"prefix":"10.1183","volume":"19","author":[{"given":"J.F.","family":"Broekmans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.B.","family":"Migliori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.L.","family":"Rieder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Lees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Ruutu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Loddenkemper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Raviglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2002,4,1]]},"reference":[{"key":"2024101809115011000_19.4.765.1","unstructured":"World Health Organization. WHO Tuberculosis Programme framework for effective tuberculosis control. World Health Organization Document WHO\/TB\/94.1: 1\u20137World Health Oranization, Geneva, 1994."},{"key":"2024101809115011000_19.4.765.2","unstructured":"World Health Organization. Tuberculosis handbook. World Health Organization Document WHO\/TB\/98.253: 1\u2013222World Health Oranization, Geneva, 1998."},{"key":"2024101809115011000_19.4.765.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)04146-9"},{"key":"2024101809115011000_19.4.765.4","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.98.12020505"},{"key":"2024101809115011000_19.4.765.5","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3003.1999.13d34.x"},{"key":"2024101809115011000_19.4.765.6","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.96.09051097"},{"key":"2024101809115011000_19.4.765.7","unstructured":"Styblo K. Tuberculosis control and surveillance In: Flenley DC, Petty TL, editors. Recent advances in respiratory medicine, number 4UK, Churchill Livingstone, 1986; pp. 77\u2013108."},{"key":"2024101809115011000_19.4.765.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199404283301702"},{"key":"2024101809115011000_19.4.765.9","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1183\/09031936.93.04101288","volume":"4","year":"1991","journal-title":"Eur Respir J"},{"key":"2024101809115011000_19.4.765.10","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1183\/09031936.93.04101159","volume":"4","year":"1991","journal-title":"Eur Respir J"},{"key":"2024101809115011000_19.4.765.11","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.161.supplement_3.ats600"},{"key":"2024101809115011000_19.4.765.12","unstructured":"Epidemiologic basis of tuberculosis control. In: Rieder HL, ed. France, International Union Against Tuberculosis and Lung Disease, 1999; pp. 1\u2013162."},{"key":"2024101809115011000_19.4.765.13","unstructured":"Swedish Institute for Infectious Disease Control, Swedish Heart Lung Foundation. The Swedish Tuberculosis Index 1998Tryck, Graphium Print and Distribution, Solna, 2000; pp. 1\u201338."},{"key":"2024101809115011000_19.4.765.14","unstructured":"Swedish Institute for Infectious Disease Control, Swedish Heart Lung Foundation. The Swedish Tuberculosis Index 1999Tryck, Graphium Print and Distribution, Solna, 2001; pp. 1\u201333."},{"key":"2024101809115011000_19.4.765.15","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.39.3.855-861.2001"},{"key":"2024101809115011000_19.4.765.16","unstructured":"EuroTB (InVS\/KNCV) and the national coordinators for tuberculosis surveillance in the WHO European Region. Surveillance of tuberculosis in Europe. Report on tuberculosis case notified in 1998. EuroTB 2001:; 1\u2013105."},{"key":"2024101809115011000_19.4.765.17","unstructured":"World Health Organization. Anti-tuberculosis drug resistance in the world. Report No.\u20052. World Health Organization Document WHO\/CDS\/TB\/2000.278: 1\u2013117World Health Organization, Geneva, 2000."},{"key":"2024101809115011000_19.4.765.18","unstructured":"World Health Organization. Global tuberculosis control. WHO report 2000. World Health Organization Document WHO\/CDS\/TB\/2000.275: 1\u2013179World Health Organization, Geneva, 2000."},{"key":"2024101809115011000_19.4.765.19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200104263441706"},{"key":"2024101809115011000_19.4.765.20","first-page":"297","volume":"71","year":"1993","journal-title":"Bull World Health Organ"},{"key":"2024101809115011000_19.4.765.21","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.94.07081545"},{"key":"2024101809115011000_19.4.765.22","first-page":"978","volume":"14","year":"1999","journal-title":"Eur Respir J"},{"key":"2024101809115011000_19.4.765.23","first-page":"1","volume":"42","year":"1969","journal-title":"Bull Int Union Tuberc"},{"key":"2024101809115011000_19.4.765.24","first-page":"149","volume":"70","year":"1992","journal-title":"Bull World Health Organ"},{"key":"2024101809115011000_19.4.765.25","doi-asserted-by":"publisher","DOI":"10.1016\/0962-8479(94)90077-9"},{"key":"2024101809115011000_19.4.765.26","doi-asserted-by":"publisher","DOI":"10.1016\/S0962-8479(05)80035-8"},{"key":"2024101809115011000_19.4.765.27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.307.6918.1539"},{"key":"2024101809115011000_19.4.765.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-3879(73)80029-7"},{"key":"2024101809115011000_19.4.765.29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0954-6111(08)80051-0","volume":"84","year":"1990","journal-title":"Respir Med"},{"key":"2024101809115011000_19.4.765.30","first-page":"417","volume":"58","year":"1992","journal-title":"Stud Pneumol Phthiseol Cechoslov"},{"key":"2024101809115011000_19.4.765.31","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1136\/bmj.319.7216.1031","volume":"319","year":"1999","journal-title":"BMJ"},{"key":"2024101809115011000_19.4.765.32","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/bmj.315.7120.1447","volume":"315","year":"1997","journal-title":"BMJ"},{"key":"2024101809115011000_19.4.765.33","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1164\/ajrccm.155.2.9032218","volume":"155","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101809115011000_19.4.765.34","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/bmj.309.6955.639","volume":"309","year":"1994","journal-title":"BMJ"},{"key":"2024101809115011000_19.4.765.35","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199809000-00017"},{"key":"2024101809115011000_19.4.765.36","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)92942-5"},{"key":"2024101809115011000_19.4.765.37","first-page":"330","volume":"45","year":"1996","journal-title":"Morb Mortal Wkly Rep"},{"key":"2024101809115011000_19.4.765.38","doi-asserted-by":"publisher","DOI":"10.1016\/0007-0971(85)90008-7"},{"key":"2024101809115011000_19.4.765.39","doi-asserted-by":"publisher","DOI":"10.1016\/0041-3879(86)90006-1"},{"key":"2024101809115011000_19.4.765.40","first-page":"16","volume":"22","year":"1988","journal-title":"J Roy Coll Phys London"},{"key":"2024101809115011000_19.4.765.41","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/00002030-199209000-00015","volume":"6","year":"1992","journal-title":"AIDS"},{"key":"2024101809115011000_19.4.765.42","first-page":"555","volume":"60","year":"1982","journal-title":"Bull World Health Organ"},{"key":"2024101809115011000_19.4.765.43","doi-asserted-by":"publisher","DOI":"10.1016\/0962-8479(92)90058-R"},{"key":"2024101809115011000_19.4.765.44","first-page":"28","volume":"17","year":"1969","journal-title":"Adv Tuberc Res"},{"key":"2024101809115011000_19.4.765.45","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1128\/jcm.33.8.2077-2081.1995","volume":"33","year":"1995","journal-title":"J Clin Microbiol"},{"key":"2024101809115011000_19.4.765.46","doi-asserted-by":"publisher","DOI":"10.1086\/314930"},{"key":"2024101809115011000_19.4.765.47","first-page":"497","volume":"212","year":"1984","journal-title":"Quarterly J Med"},{"key":"2024101809115011000_19.4.765.48","first-page":"161","volume":"88","year":"1963","journal-title":"Am Rev Respir Dis"},{"key":"2024101809115011000_19.4.765.49","first-page":"169","volume":"41","year":"1968","journal-title":"Bull Int Union Tuberc"},{"key":"2024101809115011000_19.4.765.50","first-page":"490","volume":"85","year":"1962","journal-title":"Am Rev Respir Dis"},{"key":"2024101809115011000_19.4.765.51","first-page":"419","volume":"33","year":"1965","journal-title":"Bull World Health Organ"},{"key":"2024101809115011000_19.4.765.52","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91817-6"},{"key":"2024101809115011000_19.4.765.53","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199709183371201"},{"key":"2024101809115011000_19.4.765.54","first-page":"65","volume":"54","year":"1979","journal-title":"Bull Int Union Tuberc Lung Dis"},{"key":"2024101809115011000_19.4.765.55","first-page":"204","volume":"51","year":"1996","journal-title":"Monaldi Arch Chest Dis"},{"key":"2024101809115011000_19.4.765.56","unstructured":"Norwegian Government. Regulations on refund of expenses for important drugsMinistry of Social Affairs, Oslo, 1996."},{"key":"2024101809115011000_19.4.765.57","unstructured":"World Health Organization. Tuberculosis control and medical students. World Health Organization Document WHO\/TB\/98.236:1\u201353World Health Organization, Geneva, 1998."},{"key":"2024101809115011000_19.4.765.58","unstructured":"Chemtob D, Weiser S, Yitzhak I, Weiler-Ravell D. Medical anthropology: an important adjunct to international TB control In: Reichman LB, Hershfield ES, editors. Tuberculosis. A comprehensive international approachNew York Basel, Marcel Dekker Inc., 2000; pp. 745\u2013770."},{"key":"2024101809115011000_19.4.765.59","first-page":"364","volume":"16","year":"2000","journal-title":"Eur Respir J"},{"key":"2024101809115011000_19.4.765.60","doi-asserted-by":"publisher","DOI":"10.1016\/0007-0971(81)90046-2"},{"key":"2024101809115011000_19.4.765.61","first-page":"460","volume":"126","year":"1982","journal-title":"Am Rev Respir Dis"},{"key":"2024101809115011000_19.4.765.62","unstructured":"World Health Organization. Treatment of tuberculosis: guidelines for national programmes. Second edition 1997. World Health Organization Document WHO\/TB\/97.220: 1\u201366World Health Organization, Geneva, 1997."},{"key":"2024101809115011000_19.4.765.63","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309093291108"},{"key":"2024101809115011000_19.4.765.64","first-page":"61","volume":"4","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024101809115011000_19.4.765.65","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.11.1445"},{"key":"2024101809115011000_19.4.765.66","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1164\/ajrccm.157.4.9706037","volume":"157","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101809115011000_19.4.765.67","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3003.2000.16b05.x"},{"key":"2024101809115011000_19.4.765.68","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3003.2000.16b03.x"},{"key":"2024101809115011000_19.4.765.69","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3003.2000.16b01.x"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/09031936.02.00261402","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T06:14:35Z","timestamp":1740377675000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/09031936.02.00261402"}},"subtitle":["Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Association (KNCV) Working Group"],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":69,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2002,4,1]]},"published-print":{"date-parts":[[2002,4]]}},"alternative-id":["10.1183\/09031936.02.00261402"],"URL":"https:\/\/doi.org\/10.1183\/09031936.02.00261402","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,4]]}}}